|Bid||191.79 x 800|
|Ask||196.38 x 1000|
|Day's Range||189.58 - 195.08|
|52 Week Range||181.36 - 308.15|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||26.92|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
WILMINGTON, Mass., March 13, 2023--Charles River launches Apollo, an intuitive customer platform that provides secure cloud-based access to real-time toxicology study data.
WILMINGTON, Mass., March 13, 2023--Charles River Laboratories To Present At Barclays Global Healthcare Conference
WILMINGTON, Mass., March 09, 2023--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf pHelper offering, which is designed to secure supply and streamline adeno-associated virus (AAV)-based gene therapy programs from early discovery through commercial manufacturing. It is available immediately in Research Grade (RG), High Quality (HQ), and Good Manufacturing Practice (GMP)-grade.